Four genes affecting Alzheimer's Disease (AD)(AP, PS1, PS2, and APOE) have
been identified and a fifth potential gene localized to chromosome 12. Coll
ectively these genes explain at most half of the genetic effect in AD. Unde
rstanding the genetics of AD is critical to developing new treatments. The
quest to find the remaining AD genes led us to undertake a large genomic sc
reen using over 466 families (730 affected sibpairs) in late-onset AD. In c
onjunction with this increase in power, we initiated several novel approach
es to identify potential AD-related genes. This included stratification of
the data into an autopsy-confirmed subset of 199 AD families. Each of these
targeted analyses resulted in the identification of novel regions containi
ng potential AD genetic risk factors. Our most significant finding was on c
hromosome 9 in the autopsy-confirmed subset where we obtained an MLS of 4.3
1. These approaches, together with new methodologies such as conditional li
nkage analysis, generalized family-based association tests (PDT), and a new
generation of genetic markers (SNPs), opens the door for additional AD gen
e discovery. Such strategies are necessary if we are to understand the subt
le and complex threads that, woven together, create the intricate tapestry
of AD. (C) 2000 Elsevier Science B.V. All rights reserved.